Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) was the recipient of a significant decline in short interest in the month of January. As of January 30th, there was short interest totaling 79,943 shares, a decline of 69.5% from the January 15th total of 262,261 shares. Based on an average daily volume of 1,342,034 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the shares of the company are short sold. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 1,342,034 shares, the days-to-cover ratio is presently 0.1 days.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on RBGLY. Morgan Stanley lowered Reckitt Benckiser Group from an "overweight" rating to an "equal weight" rating in a research note on Monday, December 15th. Barclays raised Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a report on Monday, December 1st. Deutsche Bank Aktiengesellschaft restated a "hold" rating on shares of Reckitt Benckiser Group in a research report on Monday, October 27th. Royal Bank Of Canada cut shares of Reckitt Benckiser Group from an "outperform" rating to a "sector perform" rating in a research note on Wednesday, January 14th. Finally, Jefferies Financial Group reiterated a "hold" rating on shares of Reckitt Benckiser Group in a research note on Wednesday, January 7th. Two analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, Reckitt Benckiser Group currently has a consensus rating of "Moderate Buy".
Read Our Latest Research Report on RBGLY
Reckitt Benckiser Group Stock Performance
Shares of OTCMKTS RBGLY opened at $17.41 on Wednesday. Reckitt Benckiser Group has a 1 year low of $11.99 and a 1 year high of $16.80. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.37 and a current ratio of 0.56. The company has a 50 day simple moving average of $16.39 and a 200-day simple moving average of $15.70.
Reckitt Benckiser Group Company Profile
(
Get Free Report)
Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.
The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A forward-looking investment report spotlighting the seven space companies best positioned to benefit from accelerating commercialization in 2026. It explores key industry trends, major growth catalysts, and the stocks shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.